Memorial Sloan-Kettering presented evidence in the current issue of findings, published in the New England Journal of Medicine that two drugs given concurrently can be safe and beneficial in treating metastatic melanoma. The drugs tested were nivolumab and ipilimumab. The result of therapy was a very rapid rate of tumor regression.
Breaking News in Metastatic Melanoma Treatment
